Celltrion and Celltrion Healthcare to Buy Back 145 Billion KRW Worth of Treasury Shares

Celltrion and Celltrion Healthcare announced on the 28th that they held a board meeting and decided to repurchase their own shares. This is a measure to stabilize the stock price and enhance shareholder value.

Celltrion will repurchase a total of 696,865 shares this time. The planned acquisition amount is approximately 100 billion KRW. Celltrion Healthcare will repurchase a total of 690,000 shares, with a planned acquisition amount of approximately 45 billion KRW. Celltrion and Celltrion Healthcare plan to acquire their own shares through on-market purchases from the 29th until November 28th.

The reason both companies decided to repurchase their own shares is that although they recently decided on a merger and presented a concrete vision for future growth engines, they judged that the company's market value continues to be undervalued due to market uncertainties. This year, Celltrion and Celltrion Healthcare repurchased 1,305,376 shares (202.4 billion KRW) and 1,215,000 shares (73 billion KRW), respectively.

The Celltrion Group stated, "The Celltrion Group will strengthen business competitiveness and strive to preserve corporate value and enhance shareholder value through securing various product pipelines, future growth engines, and expanding global sales."

This content was produced with the assistance of AI translation services.